• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

101.60 -0.35 (-0.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 835,350
Open 97.89
Bid (Size) 98.00 (1)
Ask (Size) 103.00 (1)
Prev. Close 101.95
Today's Range 97.89 - 103.42
52wk Range 25.32 - 117.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
August 02, 2025
From The Rosen Law Firm PA
Via GlobeNewswire
Why GeneDx Holdings Stock Crushed It Again Today
July 30, 2025
It continued to ride high on its solid second-quarter performance. 
Via The Motley Fool

Performance

YTD
+27.6%
+27.6%
1 Month
+10.9%
+10.9%
3 Month
+53.6%
+53.6%
6 Month
+45.2%
+45.2%
1 Year
+237.9%
+237.9%

More News

Read More
What 4 Analyst Ratings Have To Say About GeneDx Holdings
July 30, 2025
Via Benzinga
GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm
July 29, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
Earnings Scheduled For July 29, 2025
July 29, 2025
Via Benzinga
Exploring GeneDx Hldgs's Earnings Expectations
July 28, 2025
Via Benzinga
Why GeneDx Holdings Stock Blasted 8% Higher Today
July 29, 2025
Via The Motley Fool
Sanmina, Sarepta Therapeutics, Polaris, Celestica And Other Big Stocks Moving Higher On Tuesday
July 29, 2025
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
July 29, 2025
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 29, 2025
Via Benzinga
GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights
July 29, 2025
From GeneDx
Via Business Wire
GeneDx Holdings Corp (NASDAQ:WGS) Exhibits Strong Growth Momentum and Technical Strength for Potential Upside
July 29, 2025
Via Chartmill
GeneDx CFO Sells More Than Half of His Shares
July 25, 2025
Via The Motley Fool
Topics Artificial Intelligence
Bragar Eagel & Squire, P.C Continues Investigations on Behalf of Lineage, Proficient Auto, PetMed, and GeneDx and Encourages Investors to Contact the Firm
July 23, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
July 22, 2025
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C Continues Investigations on Behalf of CTO Realty, GeneDx, Quantum, and Proficient Auto and Encourages Investors to Contact the Firm
July 21, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
July 18, 2025
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C Continues Investigations on Behalf of PetMed, GeneDx, Lineage, and Proficient Auto and Encourages Investors to Contact the Firm
July 14, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
July 14, 2025
From The Rosen Law Firm PA
Via GlobeNewswire
GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025
July 10, 2025
From GeneDx
Via Business Wire
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
July 09, 2025
Via Benzinga
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
July 07, 2025
From The Rosen Law Firm PA
Via GlobeNewswire
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
July 02, 2025
From The Rosen Law Firm PA
Via GlobeNewswire
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains
June 30, 2025
Via MarketBeat
Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts
June 30, 2025
Via Benzinga

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 101.60
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 08/01/25 04:00 PM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap